Introduction {#S1}
============

Osteosarcoma is one of the most common types of bone sarcoma, accounting for approximately 20% of newly diagnosed bone cancers ([@B27]; [@B37]). The prevalence of osteosarcoma is related to bone growth and is the most malignant tumors in adolescents ([@B33]). Unlike the other tissues, there is a lot of mineral in the microenvironment matrix of bone tissue, which may play a potential role in the tumorigenesis of osteosarcoma. When mesenchymal stem cells (MSCs) were embedded in a calcified ceramic scaffold, tumoral bone formation was observed in the surroundings scaffold ([@B36]). *In vitro* experiments showed that CA^2+^ supplementation can provide bone mineralization ([@B12]). Meanwhile, selenium-doped hydroxyapatite nanoparticles could induce apoptosis of tumor cells by an inherent caspase-dependent apoptosis pathway together with the generation of reactive oxygen([@B43]). Osteosarcoma cell lines have been reported can act as osteoblasts when grown on calcified materials ([@B48]). However, the mechanisms of the mineral in the microenvironment affected by osteosarcoma are, to date, still largely unknown.

Bioinformatics, as a new technology, has been widely developed in recent years and plays an important role in revealing the internal mechanism of tumor progression and carcinogenesis at the genome level. Till date, numerous studies have been published on different cancer types, and some researches have revealed the interesting information of the expression of key genes, microRNAs and co-expression modules in osteosarcoma([@B30]; [@B31]) and drug resistance in osteosarcoma patients([@B6]).

Here we analyzed the microarray dataset obtained from osteosarcoma cells adhered to the demineralized osseous surfaces and mineralized osseous surfaces from the Gene Expression Omnibus (GEO) database to identify differentially expressed genes (DEGs). Subsequently, a protein-protein interaction (PPI) network was constructed to screen out hub genes in the DEGs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses of the DEGs and the hub genes were used to reveal the underlying mechanisms. Subsequently, we constructed regulatory networks of the hub genes. Furthermore, the hub genes survival analysis was carried out to find some candidate genes and to predict the possible function of these genes. Taken together, a total of 207 DEGs, 297 miRNAs, 349 transcription factors, 13 hub genes, and 1 candidate gene were identified.

Materials and Methods {#S2}
=====================

Identification of DEGs and Construction of PPI Network {#S2.SS1}
------------------------------------------------------

A public series submitted by Wischmann et al. in 2018, GSE114237 ([@B45]), was downloaded from the GEO^[1](#footnote1){ref-type="fn"}^ ([@B5]). The researchers had prepared 8 groups of porcine tibia slices; four groups were demineralized whereas the others were left in their native condition. Later, osteosarcoma cells (MG-63 cells) were seeded onto the osseous surfaces for 72 h. All the expression data were analyzed using the R language (version 3.5.1) BIOCONDUCTOR package, and the DEGs were screened out via the LIMMA package. The cutoff of statistical significance was *p*-values \< 0.05 and an absolute value of fold change of gene expression greater than two. The STRING database (online Search Tool for the Retrieval of Interacting Genes,^[2](#footnote2){ref-type="fn"}^) ([@B40]) was used to predict and construct PPI network with a statistical significance of interaction scores of \>0.4 (medium confidence score), and the network was visualized by Cytoscape software (version 3.7.0, [RRID: SCR_003032](https://scicrunch.org/resolver/RRID:SCR_003032); the National Resource for Network Biology \[NRNB\], Bethesda, MD, United States) ([@B38]). Subsequently, hub genes were selected via MCODE (Molecular Complex Detection, [RRID: SCR_015828](https://scicrunch.org/resolver/RRID:SCR_015828)) ([@B4]), the app of Cytoscape, employing the following criteria: MCODE score \>5.5, degree cut-off = 2, score cut-off = 0.2, max depth = 100, and k-score = 2.

Functional and Pathway Enrichment {#S2.SS2}
---------------------------------

DAVID^[3](#footnote3){ref-type="fn"}^ ([@B24]) was used to perform the biological process (BP), cellular component (CC), molecular function (MF) analysis ([@B15]), and KEGG ([@B25]) pathway enrichment analysis. The DEGs and hub genes were carried out separately with an indicated statistical significance of *p*-value \< 0.05.

Regulatory Network of the Hub Genes {#S2.SS3}
-----------------------------------

The miRDB^[4](#footnote4){ref-type="fn"}^ ([@B46]) online database was used to determine the potential miRNAs that may bind to the hub genes, which were filtered by a confidence score \>60. Additionally, the AnimalTFDB 3.0^[5](#footnote5){ref-type="fn"}^ ([@B23]), was used to further determine the potential transcription factors (TF) that might interact with hub genes and regulate their expression, filtered with *Q*-values \< 0.01. The miRNA-mRNA and TF-mRNA network were visualized via Cytoscape ([@B38]).

Survival Analysis of the Hub Genes {#S2.SS4}
----------------------------------

All the hub genes were input into the PROGgeneV2^[6](#footnote6){ref-type="fn"}^ database ([@B16]) separately, and the overall survival plot (Kaplan Meier, KM plot) for each gene was created. According to the median gene expression, the data were divided into high and low expression groups. PROGgeneV2 evaluates the prognostic implications of genes using the SURVIVAL package of the R language for a hypothesis test via publicly available data. The hub genes were considered as candidate genes with a *p*-value less than 0.05 for further analysis.

Prediction of Functions of the Candidate Genes {#S2.SS5}
----------------------------------------------

The candidate genes were submitted to the GeneMANIA^[7](#footnote7){ref-type="fn"}^ ([@B44]) to illustrate the interactive functional association network among the candidate genes and their co-expression genes. The advanced statistical options used were as follows: max resultant genes = 20, max resultant attributes = 10, using the automatically selected weighing method. Subsequently, the Anatomic Viewer of the online SAGE database (Serial Analysis of Gene Expression database,^[8](#footnote8){ref-type="fn"}^) ([@B7]) displayed the expression of candidate genes in normal and corresponding malignant human tissues. The related expression levels were ordered by different colors based on the counts of SAGE tags. Furthermore, the Open Targets Platform^[9](#footnote9){ref-type="fn"}^ ([@B9]) was used to depict relationships between the candidate genes as drug targets and diseases involved in neoplasm and skeletal system disease.

The parameter selection of all these tools above is based on the developers' references to select the most appropriate parameters.

Results {#S3}
=======

Identification of DEGs and Construction of PPI Network {#S3.SS1}
------------------------------------------------------

The profiles of the public series from GEO had a good consistency shown in [Figure 1A](#F1){ref-type="fig"}. In total, 207 DEGs were identified in the demineralized group; approximately 151 upregulated and 56 downregulated genes were identified ([Figure 1B](#F1){ref-type="fig"}). As we know, the *p*-value calculation includes the number of genes we input for the enrichment and the total number of genes set in a specific concentration; it means that if we analyze the up-and down-regulated genes together, we will get a smaller and more significant *p*-value. In this way, some underestimating important significant pathways can be avoided. The PPI network constructed via Cytoscape of the DEGs as shown in [Figure 1C](#F1){ref-type="fig"}, while the most significant module in [Figure 1D](#F1){ref-type="fig"} with 13 nodes and 33 edges. These 13 genes were proposed as hub genes (12 upregulated genes and 1 downregulated gene). The detailed information is provided in [Table 1](#T1){ref-type="table"}. The network of hub genes may be an important regulatory mechanism in osteosarcoma affected by matrix mineral.

![Boxplot, volcano plot, protein-protein interaction (PPI) network, and the most significant module of the DEGs are shown. The boxplot demonstrated that the profiles of GSE114237 had a good consistency **(A)**. The volcano plot exhibited the expression of genes between mineralized and demineralized groups with a cut-off criterion of *p*-value \< 0.01 and absolute value logFC (fold change) \>1; the red dots represent downregulated genes, the green dots represent upregulated genes, and the gray dots represent unchanged genes **(B)**. The PPI network of the DEGs was constructed and visualized by Cytoscape **(C)**; the round nodes represent upregulated proteins, the diamond nodes represent downregulated proteins, and the edges represent protein-protein associations. Besides, the yellow nodes represent the most significant module obtained from the PPI network **(D)**; the width of the edges represents the coexpression value between the nodes.](fgene-11-00533-g001){#F1}

###### 

The statistical metrics for the hub genes.

  **ID**    **Gene symbol**   ***p* value**   ***t* value**   **Log FC**   **Gene title**
  --------- ----------------- --------------- --------------- ------------ --------------------------------------------
  8095508   AMTN              0.025101        2.723250        3.127518     amelotin
  8016646   COL1A1            0.030041        2.609746        1.312103     collagen type I alpha 1 chain
  7903786   CSF1              0.016229        −3.000870       −1.147710    colony stimulating factor 1
  8023995   FSTL3             0.001664        4.555960        1.091519     follistatin like 3
  8046861   ITGAV             0.019769        2.874816        1.229955     integrin subunit alpha V
  8090162   ITGB5             0.027612        2.662971        1.191944     integrin subunit beta 5
  7971077   POSTN             0.006454        3.604433        1.214450     periostin
  7942957   PRSS23            0.032420        2.561707        1.294606     protease, serine 23
  8037005   TGFB1             0.007334        3.519042        1.241910     transforming growth factor beta 1
  7980316   TGFB3             0.005699        3.688186        2.927218     transforming growth factor beta 3
  8108217   TGFBI             0.007061        3.544310        1.128630     transforming growth factor beta induced
  8156826   TGFBR1            0.005879        3.667198        1.037752     transforming growth factor beta receptor 1
  8106743   VCAN              0.009674        3.336135        2.234149     versican

Functional and Pathway Enrichment {#S3.SS2}
---------------------------------

Results of the GO and KEGG pathway enrichment analyses of the DEGs are shown in [Figure 2](#F2){ref-type="fig"} (details are shown in [Tables 2](#T2){ref-type="table"}, [3](#T3){ref-type="table"}). In the BP ontology ([Figure 2A](#F2){ref-type="fig"}), cell adhesion (25 genes) and extracellular matrix organization (13 genes) were the most significantly enriched terms. In the CC ontology ([Figure 2B](#F2){ref-type="fig"}), the terms were related to extracellular space (34 genes) and plasma membrane (64 genes). While the terms in the MF ontology ([Figure 2C](#F2){ref-type="fig"}), were related to transforming growth factor-beta binding (4 genes) and protease binding (7 genes). Besides that, in the KEGG pathways ([Figure 2D](#F2){ref-type="fig"}), the terms were revealed to be proteoglycans in cancer (11 genes) and pathways in cancer (14 genes). Particularly, GO and KEGG pathway enrichment analysis of the hub genes showed that they were mainly related to the positive regulation of epithelial to mesenchymal transition, extracellular matrix, type II transforming growth factor-beta receptor binding, and hypertrophic cardiomyopathy ([Figure 3](#F3){ref-type="fig"}, also can be seen in [Supplementary Tables 1](#SM1){ref-type="supplementary-material"}, [2](#SM2){ref-type="supplementary-material"}). These enrichment results reveal that transforming growth factor-beta binding function, especially in the extracellular matrix, should need more attention.

![Functional and pathway enrichment analyses of the DEGs. These include the biological process **(A)**, cellular component **(B)**, molecular function **(C)** and KEGG pathway **(D)**; the size of the dots represents the gene count and the color depth of the dots represents the -log (*p*-value).](fgene-11-00533-g002){#F2}

###### 

The top five enriched GO terms of the DEGs.

  **Category**         **GO ID**   **GO term**                                                     **Count**   **FDR**    **Log P**   **Genes**
  -------------------- ----------- --------------------------------------------------------------- ----------- ---------- ----------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Biological process   0007155     cell adhesion                                                   25          6.55E-07   −9.41       PRKCA, NRP2, ATP1B1, AMTN, ITGA2, PCDHB2, NEDD9, ITGB5, SPOCK1, POSTN, MCAM, EPHA3, TNFAIP6, RGMB, KIAA1462, ITGAV, FAP, CDON, TGFBI, VCAN, COL1A1, ADAM12, BOC, FN1, MYH10
  Biological process   0030198     extracellular matrix organization                               13          0.00382    −5.64       OLFML2B, ITGA2, ITGB5, POSTN, FURIN, ITGAV, FBLN5, SERPINE1, TGFBI, VCAN, COL1A1, JAM2, FN1
  Biological process   0071560     cellular response to transforming growth factor beta stimulus   7           0.029311   −4.76       WNT5A, LIMS1, TGFBR1, POSTN, PDE3A, COL1A1, TGFB1
  Biological process   0030335     positive regulation of cell migration                           11          0.075174   −4.35       PRKCA, TNFAIP6, ITGAV, CSF1, TGFBR1, HAS2, COL1A1, HGF, MCAM, TGFB1, ACVR1
  Biological process   0001525     angiogenesis                                                    12          0.076519   −4.34       NRP2, PRKCA, FMNL3, HEY1, ITGAV, FAP, PLXDC1, TGFBI, SERPINE1, JAG1, MCAM, FN1
  Cellular component   0005615     extracellular space                                             34          0.006268   −5.31       WNT5A, FGF5, AEBP1, CPM, MASP1, CSF1, FSTL3, TGFB3, SPOCK1, POSTN, NRN1, TGFB1, ALDH3A1, SERPINE2, IFNE, FAP, TGFBI, SERPINE1, FN1, HGF, MCAM, FURIN, SLIT2, STOM, TNFAIP6, SULF2, INHBE, FBLN5, PLXDC1, FABP3, SERPINB1, VCAN, COL1A1, ADAMTS4
  Cellular component   0005578     proteinaceous extracellular matrix                              14          0.007391   −5.23       WNT5A, AMTN, ADAMTS16, OLFML2B, POSTN, SPOCK1, TGFB1, SLIT2, SMOC1, FBLN5, TGFBI, VCAN, ADAMTS4, FN1
  Cellular component   0031012     extracellular matrix                                            13          0.098728   −4.11       AEBP1, TGFB3, POSTN, TGFB1, SERPINE2, FBLN5, CDON, SERPINE1, TGFBI, VCAN, COL1A1, FN1, ADAMTS4
  Cellular component   0009986     cell surface                                                    17          0.279007   −3.66       WNT5A, ARSB, CPM, TGFBR1, TGFB3, ITGB5, TLR3, ITGA2, ADGRG2, FURIN, SLIT2, TGFB1, SLC1A4, HSPA2, SULF2, ITGAV, FAP
  Cellular component   0005886     plasma membrane                                                 64          1.063098   −3.07       SLC5A3, NRP2, ATP1B1, SLC44A1, SCN3A, TGFB3, JAG1, SLC26A2, TGFB1, EDNRA, SLC1A4, SPRY1, FAP, TGFBI, SERPINE1, NALCN, SLC4A4, BOC, KCNG1, PRKCA, FMNL3, PCDHB2, SLIT2, PLAUR, AMIGO2, PLCE1, PLXDC1, SGCD, JAM2, ADAM12, STEAP2, ARL4C, GRB14, ICOSLG, PMEPA1, WNT5A, ABCA8, LIMS1, CPM, CALD1, CSF1, ITGB5, BDKRB1, BDKRB2, NRN1, DAAM1, ALDH3A1, SERINC5, RGMB, ITGAV, TGFBR1, TSPAN13, ITGA2, NPR3, MCAM, FURIN, EPHA3, DOCK4, SULF2, CDON, SYTL5, RGS9, GFRA2, MYH10
  Molecular function   0050431     transforming growth factor beta binding                         4           0.914081   −3.19       ITGAV, TGFBR1, TGFB3, ACVR1
  Molecular function   0002020     protease binding                                                7           1.19624    −3.07       ITGAV, FAP, SERPINE1, BDKRB2, FURIN, FN1, ADAMTS4
  Molecular function   0005114     type II transforming growth factor beta receptor binding        3           3.348849   −2.62       TGFBR1, TGFB3, TGFB1
  Molecular function   0004435     phosphatidylinositol phospholipase C activity                   4           4.30035    −2.51       EDNRA, PLCE1, PLCB4, BDKRB2
  Molecular function   0008083     growth factor activity                                          7           11.86587   −2.05       FGF5, INHBE, CSF1, TGFB3, JAG1, HGF, TGFB1

###### 

The enriched KEGG pathway terms of the DEGs.

  **Pathway ID**   **Pathway name**                                            **Gene count**   **FDR**    **LogP**   **Genes**
  ---------------- ----------------------------------------------------------- ---------------- ---------- ---------- ------------------------------------------------------------------------------------------------
  hsa05205         Proteoglycans in cancer                                     11               0.384572   −3.51      PRKCA, WNT5A, PLCE1, ITGAV, ITGB5, ITGA2, HGF, MIR21, TGFB1, FN1, PLAUR
  hsa05200         Pathways in cancer                                          14               2.496893   −2.69      PRKCA, WNT5A, FGF5, TGFBR1, TGFB3, ITGA2, BDKRB1, HGF, BDKRB2, TGFB1, EDNRA, PLCB4, ITGAV, FN1
  hsa05146         Amoebiasis                                                  7                3.449882   −2.55      PRKCA, PLCB4, TGFB3, SERPINB1, COL1A1, TGFB1, FN1
  hsa05161         Hepatitis B                                                 8                3.819504   −2.50      PRKCA, EGR2, TGFBR1, TGFB3, CREB3L2, TLR3, CREB5, TGFB1
  hsa05410         Hypertrophic cardiomyopathy (HCM)                           6                4.545801   −2.43      ITGAV, TGFB3, SGCD, ITGB5, ITGA2, TGFB1
  hsa05414         Dilated cardiomyopathy                                      6                6.194945   −2.29      ITGAV, TGFB3, SGCD, ITGB5, ITGA2, TGFB1
  hsa05142         Chagas disease (American trypanosomiasis)                   6                14.38482   −1.90      PLCB4, TGFBR1, SERPINE1, TGFB3, BDKRB2, TGFB1
  hsa04610         Complement and coagulation cascades                         5                15.32817   −1.87      MASP1, SERPINE1, BDKRB1, BDKRB2, PLAUR
  hsa04918         Thyroid hormone synthesis                                   5                16.03452   −1.85      PRKCA, ATP1B1, PLCB4, CREB3L2, CREB5
  hsa04151         PI3K−Akt signaling pathway                                  11               18.46895   −1.79      PRKCA, FGF5, ITGAV, CSF1, CREB3L2, ITGB5, ITGA2, CREB5, COL1A1, HGF, FN1
  hsa04919         Thyroid hormone signaling pathway                           6                20.70627   −1.73      PRKCA, SLC16A2, ATP1B1, PLCE1, PLCB4, ITGAV
  hsa04022         cGMP-PKG signaling pathway                                  7                20.92307   −1.73      EDNRA, ATP1B1, PLCB4, CREB3L2, CREB5, PDE3A, BDKRB2
  hsa04961         Endocrine and other factor-regulated calcium reabsorption   4                23.96458   −1.66      PRKCA, ATP1B1, PLCB4, BDKRB2
  hsa04350         TGF-beta signaling pathway                                  5                27.4941    −1.59      INHBE, TGFBR1, TGFB3, TGFB1, ACVR1
  hsa04911         Insulin secretion                                           5                28.40853   −1.57      PRKCA, ATP1B1, PLCB4, CREB3L2, CREB5
  hsa04512         ECM-receptor interaction                                    5                30.26743   −1.54      ITGAV, ITGB5, ITGA2, COL1A1, FN1
                                                                                                                      

![Functional and pathway enrichment analyses of the hub genes. These include the biological process **(A)**, cellular component **(B)**, molecular function **(C)** and KEGG pathway **(D)**; the size of the dots represents the gene count and the color depth of the dots represents the -log (*p*-value).](fgene-11-00533-g003){#F3}

Regulatory Network of the Hub Genes {#S3.SS3}
-----------------------------------

In total, 297 miRNAs and 349 TFs were screened out employing a relative database (details in Methods). The miRNA-mRNA ([Figure 4A](#F4){ref-type="fig"}) and TF-mRNA ([Figure 4B](#F4){ref-type="fig"}) interaction regulatory networks were constructed and visualized with that the orange nodes represent hub genes, the purple nodes miRNAs, and the dark blue nodes TFs by Cytoscape. The top 10 miRNAs that regulated the hub genes, ranked by topological coefficients, were hsa-miR-664b-3p, hsa-miR-135a-5p, hsa-miR-548an, hsa-miR-135b-5p, hsa-miR-301a-3p, hsa-miR-301b-3p, hsa-miR-454-3p, hsa-miR-130b-3p, hsa-miR-130a-3p, and hsa-miR-128-3p. Furthermore, the top 10 TFs interacted with the hub genes, ranked by topological coefficients, were VEZF1, CHD1, POLR2A, TAF1, RUNX1T1, HCFC1, ELK4, ZEB1, CDK8, and ZNF22. The topological properties of the miRNAs and TFs are displayed in [Tables 4](#T4){ref-type="table"}, [5](#F5){ref-type="fig"}. The miRNA-mRNA network and TF-mRNA network predict the potential mechanism, which can provide evidence for subsequent experimental verification.

![miRNA-mRNA **(A)** and transcription factor-mRNA **(B)** regulatory networks of the hub genes; the orange nodes represent hub genes, the purple nodes represent miRNAs, and the dark blue nodes represent transcription factors.](fgene-11-00533-g004){#F4}

###### 

The top 10 miRNAs that regulated the hub genes and their topological properties.

  **Name**          **Average shortest path length**   **Betweenness centrality**   **Closeness centrality**   **Degree**   **Neighborhood connectivity**   **Radiality**   **Stress**   **Topological coefficient**
  ----------------- ---------------------------------- ---------------------------- -------------------------- ------------ ------------------------------- --------------- ------------ -----------------------------
  hsa-miR-664b-3p   3.12931                            0.007646                     0.319559                   2            56.5                            0.733836        8180         0.549505
  hsa-miR-135a-5p   3.12931                            0.007646                     0.319559                   2            56.5                            0.733836        8180         0.549505
  hsa-miR-548an     3.12931                            0.007646                     0.319559                   2            56.5                            0.733836        8180         0.549505
  hsa-miR-135b-5p   3.12931                            0.007646                     0.319559                   2            56.5                            0.733836        8180         0.549505
  hsa-miR-301a-3p   3.094828                           0.009452                     0.32312                    2            56.5                            0.738147        8298         0.544118
  hsa-miR-301b-3p   3.094828                           0.009452                     0.32312                    2            56.5                            0.738147        8298         0.544118
  hsa-miR-454-3p    3.094828                           0.009452                     0.32312                    2            56.5                            0.738147        8298         0.544118
  hsa-miR-130b-3p   3.094828                           0.009452                     0.32312                    2            56.5                            0.738147        8298         0.544118
  hsa-miR-130a-3p   3.094828                           0.009452                     0.32312                    2            56.5                            0.738147        8298         0.544118
  hsa-miR-128-3p    3.094828                           0.009452                     0.32312                    2            56.5                            0.738147        8298         0.544118
                                                                                                                                                                                         

###### 

The top 10 transcription factors that regulated the hub genes and their topological properties.

  **Name**   **Average shortest path length**   **Betweenness centrality**   **Closeness centrality**   **Degree**   **Neighborhood connectivity**   **Radiality**   **Stress**   **Topological coefficient**
  ---------- ---------------------------------- ---------------------------- -------------------------- ------------ ------------------------------- --------------- ------------ -----------------------------
  VEZF1      2.628809                           4.56E-05                     0.3804                     2            195.5                           0.592798        2458         0.813808
  CHD1       2.628809                           4.56E-05                     0.3804                     2            195.5                           0.592798        2458         0.813808
  POLR2A     2.628809                           4.56E-05                     0.3804                     2            195.5                           0.592798        2458         0.813808
  TAF1       2.628809                           4.56E-05                     0.3804                     2            195.5                           0.592798        2458         0.813808
  RUNX1T1    2.628809                           4.56E-05                     0.3804                     2            195.5                           0.592798        2458         0.813808
  HCFC1      2.628809                           4.56E-05                     0.3804                     2            195.5                           0.592798        2458         0.813808
  ELK4       2.512465                           7.01E-05                     0.398015                   2            203.5                           0.621884        4016         0.778846
  ZEB1       2.512465                           7.01E-05                     0.398015                   2            203.5                           0.621884        4016         0.778846
  CDK8       2.512465                           7.01E-05                     0.398015                   2            203.5                           0.621884        4016         0.778846
  ZNF22      2.67313                            4.70E-05                     0.374093                   2            180                             0.581717        2676         0.774892

Survival Analysis of the Hub Genes {#S3.SS4}
----------------------------------

The overall survival plots could be obtained for only 11 hub genes out of 13 hub genes, as shown in [Figure 5](#F5){ref-type="fig"}. However, most of them were not statistically significant. Unfortunately, there was no significant difference in the survival curve of COL1A1, CSF1, FSTL3, ITGAV, ITGB5, POSTN, PRSS23, TGFB1, TGFB3, and TGFBI, and no data result for AMTN and VCAN. Only one gene, namely TGFBR1, had a *p*-value \< 0.05. High expression of TGFBR1 had better overall survival.

![Survival curves of hub genes were created by the PROGgeneV2 online platform; the red line represents a high expression of the genes, and the green line represents a low expression of the genes.](fgene-11-00533-g005){#F5}

Since TGFBR1 is one of the hub genes involved in the regulation mechanism in osteosarcoma affected by matrix mineral, and its differential expression will affect the prognosis and survival of patients. Therefore, TGFBR1 was considered as a candidate gene for further analyses.

Prediction of Functions of the Candidate Genes {#S3.SS5}
----------------------------------------------

An interactive functional association network constructed by GeneMANIA revealed correlations among genes for the candidate gene. The gene set enriched for TGFBR1 is responsible mainly for the pathways related to TGFB (transforming growth factor-beta) receptor binding and TGFB receptor signaling ([Figure 6A](#F6){ref-type="fig"}). In our study, the expression profiles of the TGFBR1 in human tissue are displayed using SAGE. As shown, TGFBR1 mRNA in thyroid, lung, pancreas, colon, and prostate cancer tissues displayed higher levels than in the matched normal tissues ([Figure 6B](#F6){ref-type="fig"}). Subsequently, the target-disease association related to TGFBR1 in neoplasm and skeletal system disease could be determined and viewed by using the Open Targets Platform. Among the diseases, the top five diseases with a high score of TGFBR1-neoplasm association were cancer, multiple keratoacanthomata, Ferguson-Smith type carcinoma, glioma, and breast carcinoma ([Figure 7A](#F7){ref-type="fig"}). Furthermore, the top five diseases with a high score of TGFBR1-skeletal system disease association were craniosynostosis, connective tissue disease, Marfan syndrome, isolated brachycephaly, and isolated scaphocephaly ([Figure 7B](#F7){ref-type="fig"}). All these findings predict the function of TGFBR1 and can be helpful for further research.

![The functional association network **(A)** and expression profiles **(B)** of TGFBR1. In the functional association network, the edge-colors represent the bioinformatics method applied; the node-colors represent the biological functions of the set of enrichment genes. In the expression profiles, the left side represents normal tissues and the right side represents the matched cancer tissues. The related expression levels are based on analysis of the counts of SAGE tags, ordered by 10 colors.](fgene-11-00533-g006){#F6}

![The target-disease association related to TGFBR1 in neoplasm **(A)** and skeletal system disease **(B)** could be determined and viewed by the Open Targets Platform; the bubbles color and bubbles size represent the association score, and the top 10 diseases with a high score value are listed below.](fgene-11-00533-g007){#F7}

Discussion {#S4}
==========

The mineralization of the bone matrix plays a potentially important role in the process of bone formation. Osteosarcoma is an intraosseous malignancy that occurs predominantly in growing skeletal regions ([@B2]). The extracellular mineral is the main inorganic component of the bone matrix. Zhang et al. reported that osteosarcoma cell lines altered the expression of cytokines when grown on calcified materials ([@B48]). Meanwhile, Kingsley et al. found that calcium is released into bone microenvironment through osteoclastic bone resorption, leading to a "vicious circle" by its participation in different mechanisms of Parathyroid Hormone Related Protein (PTHRP) production ([@B26]). Meanwhile, Rubio et al. have demonstrated the role of microenvironment calcium matrix in the development of the osteosarcoma via embedding osteosarcoma tumor cells in calcium phosphate biomaterials ([@B36]).

In our study, a microarray dataset was analyzed to obtain DEGs from osteosarcoma cells adhering to the demineralized osseous surfaces against mineralized osseous surfaces. Altogether, 207 DEGs comprised 151 upregulated and 56 downregulated genes were identified. Subsequently, enrichment analyses of the DEGs were used to explore some other interactions. Previous studies have reported that extracellular space in the bone microenvironment is essential for osteosarcoma development ([@B8]; [@B3]; [@B11]; [@B50]). Moreover, studies have revealed that cell adhesion is a significant process of osteosarcoma, which involves a number of molecules ([@B13]; [@B21]; [@B42]). In other words, all these studies are consistent with the results obtained in our studies. In contrast, the functional analysis demonstrated the hub genes were mainly related to the positive regulation of epithelial to mesenchymal transition, extracellular matrix, type II transforming growth factor-beta receptor binding, and hypertrophic cardiomyopathy.

The hub genes were selected in the DEGs PPI network of the most significant module. Further survival analysis revealed TGFBR1 as a candidate gene because of its statistical significance. Meanwhile, some hub genes have been reported involved in the tumorigenesis and progression of osteosarcoma, such as ITGAV, POSTN, COL1A1, TGFB1, TGFB3, and ITGAV. These can be negatively regulated by miR-548c-3p, just like the target agents against integrin as reported in clinical trials, and can be potential tumor therapeutic targets ([@B32]). Moreover, high expression of POSTN (periostin, also known as osteoblast-specific factor two) in osteosarcoma is significantly associated with angiogenesis and is considered to be a promising prognostic factor in osteosarcoma patients ([@B22]). Similarly, COL1A1 also has a prognostic value in osteosarcoma patients ([@B20]). In osteosarcoma, TGFB signaling could interact with both microenvironment and tumor cells, exerting the characteristic effects of tumor precursors. Therefore, TGFBs could be considered as independent therapeutic targets for osteosarcoma ([@B29]; [@B41]; [@B47]).

In addition, a search of published literature revealed that some hub genes have been associated with tumors. VCAN is reported to be essential for migration and metastasis of breast cancer ([@B49]) and could be a potential prognostic biomarker for colon cancer ([@B10]). Moreover, knockdown of PRSS23 could inhibit EIF2 signaling, thereby suppressing the tumor growth of gastric cancer ([@B19]). Furthermore, one report has demonstrated that CSF1 could promote melanoma resistance to PD1 checkpoint blockade ([@B34]), and many reports have shown that CSF1R targeting may be beneficial by showing strong anti-tumor effects ([@B51]; [@B35]; [@B28]; [@B34]). Similarly, TGFBI has tumor-promoting and tumor-protective roles in certain gastrointestinal tract cancers ([@B18]), and in prostate cancer ([@B1]).

Particularly, the candidate gene TGFBR1 is reported to be involved in multiple biological functions in tumor. Inhibition of TGFBR1 can block the activation of fibroblasts mediated via IL1B/TGFB1 and reduce the secretion of pro-inflammatory cytokines in colorectal cancer, which would make the cancer cells more sensitive to chemotherapy. Moreover, TGFBR1 inhibitor could reduce the metastasis ability of tumor cells *in vivo* ([@B17]). It is also reported that in lung cancer TGFBR1 may be a target of tumor suppressor genes ([@B14]). However, there are few reports on the function of TGFBR1 in osteosarcoma. Upregulated TGFBR1 will induce the epithelial-to-mesenchymal transition in osteosarcoma cell lines, which is regulated by the interferon consensus sequence-binding protein, but the specific mechanism is not fully elaborated (ICSBP) ([@B39]).

This bioinformatics study provides information on DEGs and regulatory elements involved in osteosarcoma affected by matrix mineral. However, the mechanism of these molecules are still unknown, and additional well-designed experiments and analyses are required. In addition, all the results from this study were got *in silico*. Further, *in vivo* and *in vitro* experiments are necessary to test the biological functions of the key genes and their regulatory elements.

In conclusion, we identified 207 DEGs, 13 hub genes, 297 miRNAs, 349 TFs, and 1 candidate gene, which may be involved in the processes of matrix mineralization that may provide a functional signal to osteosarcoma cells. The molecules that we found may be potential targets for future research on the microenvironment of osteosarcoma. Furthermore, our results may contribute to the identification of the biomarkers for matrix mineralization related to osteosarcoma.
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DEGs

:   differentially expressed genes

GEO

:   gene expression omnibus
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